Pliant Therapeutics (PLRX) Change in Acquisitions & Divestments (2019 - 2026)

Pliant Therapeutics (PLRX) has reported Change in Acquisitions & Divestments for 8 consecutive years, with $60.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 27.33% year-over-year to $60.7 million; the TTM figure through Mar 2026 stood at $315.1 million (down 3.22% YoY), while the FY2025 annual figure was $337.9 million, down 4.94% from the prior year.
• Change in Acquisitions & Divestments declined to $60.7 million in Q1 2026 per PLRX's latest filing, from $86.9 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $152.8 million in Q3 2023 and bottomed at $33.8 million in Q3 2022.
• Historically, Change in Acquisitions & Divestments has averaged $81.7 million across 5 years, with a median of $83.5 million in 2025.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments plunged 55.36% — and 2023, when it surged 352.17%.
• Pliant Therapeutics' Change in Acquisitions & Divestments stood at $56.5 million in 2022, then soared by 58.36% to $89.5 million in 2023, then declined by 18.76% to $72.7 million in 2024, then increased by 19.48% to $86.9 million in 2025, then slumped by 30.11% to $60.7 million in 2026.
• Business Quant data shows PLRX's Change in Acquisitions & Divestments at $60.7 million in Q1 2026, $86.9 million in Q4 2025, and $80.3 million in Q3 2025.